4T1
|
IC50 |
1.3 μM
Compound: Nocodazole
|
Cytotoxicity against mouse 4T1 cells assessed as decrease in cell viability after 24 hrs by MTT assay
Cytotoxicity against mouse 4T1 cells assessed as decrease in cell viability after 24 hrs by MTT assay
|
[PMID: 27496212]
|
A-375
|
IC50 |
0.2 μM
Compound: Nocodazole
|
Anticancer activity against human A375 cells by MTT assay
Anticancer activity against human A375 cells by MTT assay
|
10.1039/C4MD00219A
|
A549
|
GI50 |
< 0.01 μM
Compound: Nocodazole
|
Antiproliferative activity against human A549 cells after 48 hrs by SRB cell proliferation assay
Antiproliferative activity against human A549 cells after 48 hrs by SRB cell proliferation assay
|
[PMID: 29089233]
|
A549
|
IC50 |
< 0.1 μM
Compound: Nocodazole
|
Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by SRB assay
Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by SRB assay
|
10.1039/C0MD00263A
|
A549
|
GI50 |
< 0.1 μM
Compound: Nocodozole
|
Growth inhibition of human A549 cells by Sulforhodamine B assay
Growth inhibition of human A549 cells by Sulforhodamine B assay
|
[PMID: 21106458]
|
A549
|
GI50 |
0.02 μM
Compound: Nocadazole
|
Antiproliferative activity against human A549 cells after 48 hrs by SRB assay
Antiproliferative activity against human A549 cells after 48 hrs by SRB assay
|
[PMID: 25827522]
|
A549
|
GI50 |
0.08 μM
Compound: Nocodazole
|
Anticancer activity against human A549 cells after 48 hrs by SRB assay
Anticancer activity against human A549 cells after 48 hrs by SRB assay
|
[PMID: 27130357]
|
A549
|
IC50 |
0.087 μM
Compound: Nocodazole
|
Cytotoxicity against human A549 cells by MTT assay
Cytotoxicity against human A549 cells by MTT assay
|
[PMID: 21954851]
|
A549
|
GI50 |
0.09 μM
Compound: Nocodazole
|
Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by SRB assay
Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs by SRB assay
|
[PMID: 28117204]
|
A549
|
IC50 |
|
Growth inhibition of human A549 cells after 72 hrs by MTT assay
Growth inhibition of human A549 cells after 72 hrs by MTT assay
|
[PMID: 25262051]
|
A549
|
IC50 |
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
10.1039/C5MD00150A
|
A549
|
IC50 |
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 30878833]
|
A549
|
GI50 |
0.21 μM
Compound: Nocodazole
|
Growth inhibition of human A549 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human A549 cells after 48 hrs by sulforhodamine B assay
|
10.1039/C0MD00177E
|
A549
|
IC50 |
0.272 μM
Compound: Nocodazole
|
Antiproliferative activity against human A549 cells assessed as cell growth inhibition incubated for 72 hrs by CellTiter96 Aqueous one solution cell proliferation assay
Antiproliferative activity against human A549 cells assessed as cell growth inhibition incubated for 72 hrs by CellTiter96 Aqueous one solution cell proliferation assay
|
[PMID: 32551013]
|
A549
|
GI50 |
0.5 μM
Compound: Nocodozole
|
Cytotoxicity against human A549 cells after 48 hrs by SRB assay
Cytotoxicity against human A549 cells after 48 hrs by SRB assay
|
[PMID: 20529689]
|
A549
|
IC50 |
|
Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 30108808]
|
A549
|
IC50 |
0.89 μM
Compound: Nocodazole
|
Cytotoxicity against human A549 cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 25599948]
|
A549
|
IC50 |
0.9 μM
Compound: Nocodazole
|
Antiproliferative activity against human A549 cells after 48 hrs by SRB assay
Antiproliferative activity against human A549 cells after 48 hrs by SRB assay
|
[PMID: 28988624]
|
A549
|
IC50 |
|
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 30108921]
|
A549
|
IC50 |
1.38 μM
Compound: Nacodazole
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31546197]
|
A549
|
IC50 |
1.393 μM
Compound: Nocodazole
|
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 30108815]
|
A549
|
IC50 |
1.513 μM
Compound: Nocodazole
|
Anticancer activity against human A549 cells after 48 hrs by MTT assay
Anticancer activity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 28789894]
|
A549
|
IC50 |
1.62 μM
Compound: Nocodazole
|
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
Antiproliferative activity against human A549 cells after 48 hrs by MTT assay
|
10.1039/C4MD00400K
|
A549
|
IC50 |
1.807 μM
Compound: Nocodazole
|
Antiproliferative activity against human A549 cells incubated for 48 hrs by MTT assay
Antiproliferative activity against human A549 cells incubated for 48 hrs by MTT assay
|
[PMID: 33316752]
|
A549
|
IC50 |
1.807 μM
Compound: Nocodazole
|
Cytotoxicity against human A549 cells assessed as inhibition of cell growth by MTT assay
Cytotoxicity against human A549 cells assessed as inhibition of cell growth by MTT assay
|
[PMID: 31926469]
|
A549
|
IC50 |
1.87 μM
Compound: Nocodazole
|
Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as cell growth inhibition after 48 hrs by MTT assay
|
[PMID: 28668476]
|
A549
|
IC50 |
1.87 μM
Compound: Nocodazole
|
Anticancer activity against human A549 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
Anticancer activity against human A549 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
|
[PMID: 26231080]
|
A549
|
EC50 |
106.5 nM
Compound: Nocodazole
|
Cell cycle arrest in human A549 cells assessed as accumulation at G2/M phase after 24 hrs using propidium iodide staining by flow cytometry
Cell cycle arrest in human A549 cells assessed as accumulation at G2/M phase after 24 hrs using propidium iodide staining by flow cytometry
|
[PMID: 20110137]
|
A549
|
IC50 |
2.3 μM
Compound: Nocodazole
|
Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 28684120]
|
A549
|
IC50 |
2.31 μM
Compound: nocodazole
|
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 23748152]
|
A549
|
IC50 |
2.5 μM
Compound: Nocodazole
|
Anticancer activity against human A549 cells by MTT assay
Anticancer activity against human A549 cells by MTT assay
|
10.1039/C4MD00219A
|
A549
|
IC50 |
3.63 μM
Compound: Nocodazole
|
Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 32717368]
|
A549
|
IC50 |
36.6 nM
Compound: Nocodazole
|
Cytotoxicity against human A549 cells after 24 hrs by MTT assay
Cytotoxicity against human A549 cells after 24 hrs by MTT assay
|
[PMID: 20110137]
|
B16
|
IC50 |
0.69 μM
Compound: Nocodazole
|
Antiproliferative activity against mouse B16 cells after 48 hrs by MTT assay
Antiproliferative activity against mouse B16 cells after 48 hrs by MTT assay
|
10.1039/C4MD00400K
|
B16-F10
|
IC50 |
3.12 μM
Compound: Nocodazole
|
Cytotoxicity against mouse B16-F10 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against mouse B16-F10 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 32717368]
|
BT-474
|
IC50 |
0.87 μM
Compound: Nocodazole
|
Cytotoxicity against human BT-474 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human BT-474 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 34095841]
|
BT-474
|
IC50 |
2.72 μM
Compound: Nocodazole
|
Cytotoxicity against human BT-474 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human BT-474 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 32717368]
|
BT-549
|
IC50 |
0.069 μM
Compound: Nocodazole
|
Antiproliferative activity against human BT549 cells after 48 hrs by alamar blue assay
Antiproliferative activity against human BT549 cells after 48 hrs by alamar blue assay
|
[PMID: 21563750]
|
CAPAN-1
|
IC50 |
0.13 μM
Compound: Nocodazole
|
Antiproliferative activity against human CAPAN-1 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
Antiproliferative activity against human CAPAN-1 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
|
[PMID: 37252100]
|
COLO 205
|
IC50 |
0.088 μM
Compound: Nocodazole
|
Antiproliferative activity against human COLO205 cells after 48 hrs by alamar blue assay
Antiproliferative activity against human COLO205 cells after 48 hrs by alamar blue assay
|
[PMID: 21563750]
|
Cortical neurone
|
IC50 |
0.097 μM
Compound: Nocodazole
|
Neurotoxicity in rat cortical neuron assessed as inhibition of neurite outgrowth by measuring mean neurite average length incubated for 72 hrs by Hoechst 33342 staining based ArrayScan analysis
Neurotoxicity in rat cortical neuron assessed as inhibition of neurite outgrowth by measuring mean neurite average length incubated for 72 hrs by Hoechst 33342 staining based ArrayScan analysis
|
[PMID: 31841637]
|
Cortical neurone
|
IC50 |
0.0997 μM
Compound: Nocodazole
|
Neurotoxicity in rat cortical neuron assessed as inhibition of neurite total length per neuron incubated for 72 hrs by Hoechst 33342 staining based ArrayScan analysis
Neurotoxicity in rat cortical neuron assessed as inhibition of neurite total length per neuron incubated for 72 hrs by Hoechst 33342 staining based ArrayScan analysis
|
[PMID: 31841637]
|
Cortical neurone
|
IC50 |
2.22 μM
Compound: Nocodazole
|
Neurotoxicity in rat cortical neuron assessed as inhibition of valid neuron count incubated for 72 hrs by Hoechst 33342 staining based ArrayScan analysis
Neurotoxicity in rat cortical neuron assessed as inhibition of valid neuron count incubated for 72 hrs by Hoechst 33342 staining based ArrayScan analysis
|
[PMID: 31841637]
|
DLD-1
|
IC50 |
0.19 μM
Compound: Nocodazole
|
Antiproliferative activity against human DLD1 cells after 48 hrs by alamar blue assay
Antiproliferative activity against human DLD1 cells after 48 hrs by alamar blue assay
|
[PMID: 21563750]
|
DU-145
|
IC50 |
< 0.1 μM
Compound: Nocodazole
|
Cytotoxicity against human DU145 cells assessed as growth inhibition after 48 hrs by SRB assay
Cytotoxicity against human DU145 cells assessed as growth inhibition after 48 hrs by SRB assay
|
10.1039/C0MD00263A
|
DU-145
|
GI50 |
0.011 μM
Compound: Nacodazole
|
Antiproliferative activity against human DU145 cells by SRB assay
Antiproliferative activity against human DU145 cells by SRB assay
|
[PMID: 31546197]
|
DU-145
|
GI50 |
0.19 μM
Compound: Nocodazole
|
Growth inhibition of human DU145 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human DU145 cells after 48 hrs by sulforhodamine B assay
|
10.1039/C0MD00177E
|
DU-145
|
IC50 |
0.25 μM
Compound: Nocodazole
|
Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay
Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay
|
10.1039/C4MD00400K
|
DU-145
|
IC50 |
1.14 μM
Compound: Nocodazole
|
Cytotoxicity in human DU145 cells incubated for 48 hrs by MTT assay
Cytotoxicity in human DU145 cells incubated for 48 hrs by MTT assay
|
[PMID: 28923381]
|
DU-145
|
IC50 |
1.259 μM
Compound: Nocodazole
|
Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
|
[PMID: 30108815]
|
DU-145
|
IC50 |
1.38 μM
Compound: Nacodazole
|
Antiproliferative activity against human DU145 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human DU145 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31546197]
|
DU-145
|
IC50 |
|
Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
|
[PMID: 30108921]
|
DU-145
|
IC50 |
1.698 μM
Compound: Nocodazole
|
Anticancer activity against human DU145 cells after 48 hrs by MTT assay
Anticancer activity against human DU145 cells after 48 hrs by MTT assay
|
[PMID: 28789894]
|
DU-145
|
IC50 |
2.1 μM
Compound: Nocodazole
|
Anticancer activity against human DU145 cells by MTT assay
Anticancer activity against human DU145 cells by MTT assay
|
10.1039/C4MD00219A
|
DU-145
|
IC50 |
2.2 μM
Compound: Nocodazole
|
Cytotoxicity against human DU145 cells assessed as decrease in cell viability after 24 hrs by MTT assay
Cytotoxicity against human DU145 cells assessed as decrease in cell viability after 24 hrs by MTT assay
|
[PMID: 27496212]
|
DU-145
|
IC50 |
2.8 μM
Compound: nocodazole
|
Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
Cytotoxicity against human DU145 cells after 48 hrs by MTT assay
|
[PMID: 23748152]
|
DU-145
|
IC50 |
3.2 μM
Compound: Nocodazole
|
Cytotoxicity against human DU145 cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity against human DU145 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 25599948]
|
HaCaT
|
IC50 |
1.19 μM
Compound: Nocodazole
|
Cytotoxicity against human HaCaT cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human HaCaT cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 34095841]
|
HaCaT
|
IC50 |
8.9 μM
Compound: Nocodazole
|
Cytotoxic activity against human HaCaT cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
Cytotoxic activity against human HaCaT cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
|
[PMID: 26231080]
|
HCT-116
|
IC50 |
0.13 μM
Compound: Nocodazole
|
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
|
[PMID: 37252100]
|
HCT-116
|
IC50 |
0.173 μM
Compound: Nocodazole
|
Cytotoxicity against human HCT116 cells by SRB assay
Cytotoxicity against human HCT116 cells by SRB assay
|
[PMID: 21954851]
|
HCT-116
|
IC50 |
1.06 μM
Compound: Nocodazole
|
Cytotoxicity in human HCT116 cells incubated for 48 hrs by MTT assay
Cytotoxicity in human HCT116 cells incubated for 48 hrs by MTT assay
|
[PMID: 28923381]
|
HCT-116
|
IC50 |
1.262 μM
Compound: Nocodazole
|
Anticancer activity against human HCT116 cells after 48 hrs by MTT assay
Anticancer activity against human HCT116 cells after 48 hrs by MTT assay
|
[PMID: 28789894]
|
HCT-116
|
IC50 |
1.38 μM
Compound: Nacodazole
|
Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31546197]
|
HCT-116
|
IC50 |
2.82 μM
Compound: Nocodazole
|
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 32717368]
|
HEK293
|
IC50 |
2.2 μM
Compound: Nacodazole
|
Cytotoxicity against HEK293 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Cytotoxicity against HEK293 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31546197]
|
HEK293
|
IC50 |
5.1 μM
Compound: Nocodazole
|
Cytotoxicity against human HEK293 cells assessed as decrease in cell viability after 24 hrs by MTT assay
Cytotoxicity against human HEK293 cells assessed as decrease in cell viability after 24 hrs by MTT assay
|
[PMID: 27496212]
|
HeLa
|
GI50 |
< 0.01 μM
Compound: Nacodazole
|
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 48 hrs by SRB assay
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 48 hrs by SRB assay
|
[PMID: 31546197]
|
HeLa
|
GI50 |
< 0.01 μM
Compound: Nocodazole
|
Antiproliferative activity against human HeLa cells after 48 hrs by SRB cell proliferation assay
Antiproliferative activity against human HeLa cells after 48 hrs by SRB cell proliferation assay
|
[PMID: 29089233]
|
HeLa
|
GI50 |
< 0.01 μM
Compound: Nocodazole
|
Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
|
[PMID: 27688193]
|
HeLa
|
GI50 |
0.011 μM
Compound: Nacodazole
|
Antiproliferative activity against human HeLa cells by SRB assay
Antiproliferative activity against human HeLa cells by SRB assay
|
[PMID: 31546197]
|
HeLa
|
GI50 |
0.015 μM
Compound: Nocadazole
|
Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
|
[PMID: 25827522]
|
HeLa
|
GI50 |
0.063 μM
Compound: Nocodazole
|
Anticancer activity against human HeLa cells after 48 hrs by SRB assay
Anticancer activity against human HeLa cells after 48 hrs by SRB assay
|
[PMID: 27130357]
|
HeLa
|
GI50 |
0.086 μM
Compound: Nocodazole
|
Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by SRB assay
Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs by SRB assay
|
[PMID: 28117204]
|
HeLa
|
IC50 |
|
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 30878833]
|
HeLa
|
IC50 |
0.71 μM
Compound: nocodazole
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 23748152]
|
HeLa
|
GI50 |
0.75 μM
Compound: Nocodazole
|
Growth inhibition of human HeLa cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human HeLa cells after 48 hrs by sulforhodamine B assay
|
10.1039/C0MD00177E
|
HeLa
|
GI50 |
0.75 μM
Compound: Nocodozole
|
Growth inhibition of human HeLa cells by Sulforhodamine B assay
Growth inhibition of human HeLa cells by Sulforhodamine B assay
|
[PMID: 21106458]
|
HeLa
|
GI50 |
0.81 μM
Compound: Nocodazole
|
Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
|
[PMID: 27344493]
|
HeLa
|
GI50 |
|
Antiproliferative activity against human HeLa cells assessed as growth inhibition after 48 hrs by SRB assay
Antiproliferative activity against human HeLa cells assessed as growth inhibition after 48 hrs by SRB assay
|
[PMID: 25131956]
|
HeLa
|
IC50 |
|
Antiproliferative activity against human HeLa cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human HeLa cells after 48 hrs by sulforhodamine B assay
|
[PMID: 30108808]
|
HeLa
|
IC50 |
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 30108921]
|
HeLa
|
IC50 |
1.1 μM
Compound: Nocodazole
|
Cytotoxicity against human HeLa cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 25599948]
|
HeLa
|
IC50 |
1.11 μM
Compound: Nocodazole
|
Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 34095841]
|
HeLa
|
IC50 |
1.2 μM
Compound: Nocodazole
|
Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
|
[PMID: 28988624]
|
HeLa
|
IC50 |
1.6 μM
Compound: Nocodazole
|
Antiproliferative activity against human HeLa cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human HeLa cells after 48 hrs by sulforhodamine B assay
|
[PMID: 28684120]
|
HeLa
|
IC50 |
1.611 μM
Compound: Nocodazole
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 30108815]
|
HeLa
|
IC50 |
178 nM
Compound: Nocodazole
|
Cytotoxicity against human HeLa cells after 24 to 48 hrs by trypan blue assay
Cytotoxicity against human HeLa cells after 24 to 48 hrs by trypan blue assay
|
[PMID: 23445405]
|
HeLa
|
IC50 |
2.23 μM
Compound: Nocodazole
|
Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
|
10.1039/C4MD00400K
|
HeLa
|
IC50 |
2.83 μM
Compound: Nocodazole
|
Cytotoxicity against human HeLa cells assessed as cell growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as cell growth inhibition after 48 hrs by MTT assay
|
[PMID: 28668476]
|
HeLa
|
IC50 |
2.83 μM
Compound: Nocodazole
|
Anticancer activity against human HeLa cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
Anticancer activity against human HeLa cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
|
[PMID: 26231080]
|
HeLa
|
EC50 |
40 nM
Compound: Nocodazole
|
Antiproliferative activity against human HeLa cells assessed as reduction in cell growth after 48 hrs by resazurin dye based fluorescence assay
Antiproliferative activity against human HeLa cells assessed as reduction in cell growth after 48 hrs by resazurin dye based fluorescence assay
|
[PMID: 31735573]
|
HepG2
|
GI50 |
< 0.01 μM
Compound: Nacodazole
|
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by SRB assay
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by SRB assay
|
[PMID: 31546197]
|
HepG2
|
IC50 |
< 0.1 μM
Compound: Nocodazole
|
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 48 hrs by SRB assay
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 48 hrs by SRB assay
|
10.1039/C0MD00263A
|
HepG2
|
GI50 |
0.011 μM
Compound: Nacodazole
|
Antiproliferative activity against human HepG2 cells by SRB assay
Antiproliferative activity against human HepG2 cells by SRB assay
|
[PMID: 31546197]
|
HepG2
|
IC50 |
|
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 30878833]
|
HepG2
|
GI50 |
0.76 μM
Compound: Nocodazole
|
Growth inhibition of human HepG2 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human HepG2 cells after 48 hrs by sulforhodamine B assay
|
10.1039/C0MD00177E
|
HepG2
|
IC50 |
1.1 μM
Compound: Nocodazole
|
Antiproliferative activity against human HepG2 cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human HepG2 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 28684120]
|
HL-60
|
IC50 |
0.1 μM
Compound: Nocodazole
|
Antiproliferative activity against human HL-60 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
Antiproliferative activity against human HL-60 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
|
[PMID: 37252100]
|
HMEC
|
IC50 |
|
Antiproliferative activity against human HMEC cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human HMEC cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 30878833]
|
HT-1080
|
IC50 |
|
Growth inhibition of human HT1080 cells after 72 hrs by MTT assay
Growth inhibition of human HT1080 cells after 72 hrs by MTT assay
|
[PMID: 25262051]
|
HT-1080
|
IC50 |
|
Antiproliferative activity against human HT1080 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human HT1080 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
10.1039/C5MD00150A
|
HT-29
|
IC50 |
2.2 μM
Compound: Nacodazole
|
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31546197]
|
IMR-32
|
GI50 |
< 0.01 μM
Compound: Nacodazole
|
Antiproliferative activity against human IMR32 cells assessed as reduction in cell viability after 48 hrs by SRB assay
Antiproliferative activity against human IMR32 cells assessed as reduction in cell viability after 48 hrs by SRB assay
|
[PMID: 31546197]
|
IMR-32
|
IC50 |
1.3 μM
Compound: Nocodazole
|
Antiproliferative activity against human IMR32 cells after 48 hrs by SRB assay
Antiproliferative activity against human IMR32 cells after 48 hrs by SRB assay
|
[PMID: 28988624]
|
K562
|
IC50 |
0.07 μM
Compound: Nocodazole
|
Antiproliferative activity against human K562 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
Antiproliferative activity against human K562 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
|
[PMID: 37252100]
|
K562
|
IC50 |
0.22 μM
Compound: Nocodazole
|
Antiproliferative activity against human K562 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
Antiproliferative activity against human K562 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
|
[PMID: 33212157]
|
KB
|
IC50 |
0.14 μM
Compound: Nocodazole
|
Cytotoxicity against human KB/HeLa cells after 48 hrs by XTT assay
Cytotoxicity against human KB/HeLa cells after 48 hrs by XTT assay
|
[PMID: 21705223]
|
KB
|
IC50 |
0.14 μM
Compound: Nocodazole
|
Antiproliferative activity against human KB/HeLa cells after 48 hrs by XTT assay
Antiproliferative activity against human KB/HeLa cells after 48 hrs by XTT assay
|
[PMID: 20537765]
|
KB
|
IC50 |
0.14 μM
Compound: nocodazole
|
Cytotoxicity against human KB/HeLa cells after 48 hrs by XTT assay
Cytotoxicity against human KB/HeLa cells after 48 hrs by XTT assay
|
[PMID: 17973361]
|
KB
|
IC50 |
0.14 μM
Compound: nocodazole
|
Antiproliferative activity against KB/HeLa cells by XTT assay after 48 hrs
Antiproliferative activity against KB/HeLa cells by XTT assay after 48 hrs
|
[PMID: 17181164]
|
KB
|
IC50 |
0.14 μM
Compound: nocodazole
|
Antiproliferative activity against human KB/HeLa cells by XTT assay
Antiproliferative activity against human KB/HeLa cells by XTT assay
|
[PMID: 19220018]
|
KB
|
IC50 |
0.14 μM
Compound: Nocodazole
|
Cytotoxic activity against cellular metabolic activity of Cervix KB/HeLa tumor cell line using XTT proliferation assay after incubation with the compound for 48 h
Cytotoxic activity against cellular metabolic activity of Cervix KB/HeLa tumor cell line using XTT proliferation assay after incubation with the compound for 48 h
|
[PMID: 12852768]
|
KB
|
EC50 |
91 nM
Compound: Nocodazole
|
Cell cycle arrest in human KB/HeLa cells assessed as accumulation at G2/M phase after 24 hrs using propidium iodide staining by FACS analysis
Cell cycle arrest in human KB/HeLa cells assessed as accumulation at G2/M phase after 24 hrs using propidium iodide staining by FACS analysis
|
[PMID: 20537765]
|
KB
|
EC50 |
91 nM
Compound: nocodazole
|
Cell cycle arrest in human KB/HeLa cells assessed as G2/M phase accumulation after 24 hrs by FACS analysis
Cell cycle arrest in human KB/HeLa cells assessed as G2/M phase accumulation after 24 hrs by FACS analysis
|
[PMID: 19220018]
|
KB
|
EC50 |
91 nM
Compound: Nocodazole
|
Cell cycle arrest in human KB/HeLa cells assessed as accumulation of cells at G2/M phase after 24 hrs by flow cytometry
Cell cycle arrest in human KB/HeLa cells assessed as accumulation of cells at G2/M phase after 24 hrs by flow cytometry
|
[PMID: 21705223]
|
KB
|
EC50 |
91 nM
Compound: nocodazole
|
Cell cycle arrest in KB/HeLa cells assessed as accumulation at G2/M phase after 24 hrs by flow cytometric analysis
Cell cycle arrest in KB/HeLa cells assessed as accumulation at G2/M phase after 24 hrs by flow cytometric analysis
|
[PMID: 17973361]
|
KB
|
EC50 |
91 nM
Compound: nocodazole
|
Cell cycle arrest in KB/HeLa cells by accumulation at G2/M phase
Cell cycle arrest in KB/HeLa cells by accumulation at G2/M phase
|
[PMID: 17181164]
|
L02
|
IC50 |
|
Antiproliferative activity against human HL7702 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human HL7702 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 30878833]
|
L1210
|
IC50 |
> 5 μM
Compound: nocodazole
|
Antiproliferative activity against vincristine-resistance MRP1 negative mouse L1210 cells expressing human MDR1 after 48 hrs by XTT assay
Antiproliferative activity against vincristine-resistance MRP1 negative mouse L1210 cells expressing human MDR1 after 48 hrs by XTT assay
|
[PMID: 19220018]
|
L1210
|
IC50 |
0.05 μM
Compound: Nocodazole
|
Antiproliferative activity against mouse L1210 cells after 48 hrs by XTT assay
Antiproliferative activity against mouse L1210 cells after 48 hrs by XTT assay
|
[PMID: 20537765]
|
L1210
|
IC50 |
0.05 μM
Compound: nocodazole
|
Antiproliferative activity against L1210 cells by XTT assay after 48 hrs
Antiproliferative activity against L1210 cells by XTT assay after 48 hrs
|
[PMID: 17181164]
|
L1210
|
IC50 |
0.06 μM
Compound: Nocodazole
|
Antiproliferative activity against mouse L1210 cells after 48 hrs by XTT assay
Antiproliferative activity against mouse L1210 cells after 48 hrs by XTT assay
|
[PMID: 21705223]
|
L1210
|
IC50 |
0.06 μM
Compound: nocodazole
|
Antiproliferative activity against mouse L1210 cells after 48 hrs by XTT assay
Antiproliferative activity against mouse L1210 cells after 48 hrs by XTT assay
|
[PMID: 19220018]
|
L1210
|
IC50 |
0.06 μM
Compound: nocodazole
|
Antiproliferative activity against mouse L1210 cells after 48 hrs by XTT assay
Antiproliferative activity against mouse L1210 cells after 48 hrs by XTT assay
|
[PMID: 17973361]
|
L1210
|
IC50 |
0.07 μM
Compound: Nocodazole
|
Antiproliferative activity against mouse VCR-resistant L1210 cells after 48 hrs by XTT assay
Antiproliferative activity against mouse VCR-resistant L1210 cells after 48 hrs by XTT assay
|
[PMID: 21705223]
|
L1210
|
IC50 |
0.07 μM
Compound: nocodazole
|
Antiproliferative activity against mouse vincristine-resistant L1210 cells after 48 hrs by XTT assay
Antiproliferative activity against mouse vincristine-resistant L1210 cells after 48 hrs by XTT assay
|
[PMID: 17973361]
|
L1210
|
IC50 |
0.09 μM
Compound: Nocodazole
|
Antiproliferative activity against vincristine-resistant mouse L1210 cells after 48 hrs by XTT assay
Antiproliferative activity against vincristine-resistant mouse L1210 cells after 48 hrs by XTT assay
|
[PMID: 20537765]
|
L1210
|
IC50 |
0.09 μM
Compound: nocodazole
|
Antiproliferative activity against L1210 VCR cells by XTT assay after 48 hrs
Antiproliferative activity against L1210 VCR cells by XTT assay after 48 hrs
|
[PMID: 17181164]
|
LN-229
|
IC50 |
0.1 μM
Compound: Nocodazole
|
Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
|
[PMID: 37252100]
|
LT12 tumor cell line
|
IC50 |
0.006 μM
Compound: nocodazole
|
Antiproliferative activity against rat LT12 cells after 48 hrs by XTT assay
Antiproliferative activity against rat LT12 cells after 48 hrs by XTT assay
|
[PMID: 19220018]
|
LT12 tumor cell line
|
IC50 |
0.04 μM
Compound: Nocodazole
|
Antiproliferative activity against rat LT12 cells after 48 hrs by XTT assay
Antiproliferative activity against rat LT12 cells after 48 hrs by XTT assay
|
[PMID: 21705223]
|
LT12 tumor cell line
|
IC50 |
0.04 μM
Compound: Nocodazole
|
Antiproliferative activity against rat LT12 cells after 48 hrs by XTT assay
Antiproliferative activity against rat LT12 cells after 48 hrs by XTT assay
|
[PMID: 20537765]
|
LT12 tumor cell line
|
IC50 |
0.04 μM
Compound: nocodazole
|
Antiproliferative activity against LT12 cells by XTT assay after 48 hrs
Antiproliferative activity against LT12 cells by XTT assay after 48 hrs
|
[PMID: 17181164]
|
LT12 tumor cell line
|
IC50 |
0.07 μM
Compound: Nocodazole
|
Antiproliferative activity against rat multiple drug-resistant LT12 cells after 48 hrs by XTT assay
Antiproliferative activity against rat multiple drug-resistant LT12 cells after 48 hrs by XTT assay
|
[PMID: 21705223]
|
LT12 tumor cell line
|
IC50 |
0.07 μM
Compound: Nocodazole
|
Antiproliferative activity against multi drug-resistant rat LT12 cells after 48 hrs by XTT assay
Antiproliferative activity against multi drug-resistant rat LT12 cells after 48 hrs by XTT assay
|
[PMID: 20537765]
|
LT12 tumor cell line
|
IC50 |
0.4 μM
Compound: nocodazole
|
Antiproliferative activity against rat LT12 cells ectopic expression of human MDR1 after 48 hrs by XTT assay
Antiproliferative activity against rat LT12 cells ectopic expression of human MDR1 after 48 hrs by XTT assay
|
[PMID: 19220018]
|
MCF7
|
GI50 |
< 0.01 μM
Compound: Nacodazole
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by SRB assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by SRB assay
|
[PMID: 31546197]
|
MCF7
|
GI50 |
< 0.1 μM
Compound: Nocodozole
|
Growth inhibition of human MCF7 cells by Sulforhodamine B assay
Growth inhibition of human MCF7 cells by Sulforhodamine B assay
|
[PMID: 21106458]
|
MCF7
|
IC50 |
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 30878833]
|
MCF7
|
IC50 |
0.42 μM
Compound: Nocodazole
|
Cytotoxicity against human MCF7 cells assessed as decrease in cell viability after 24 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as decrease in cell viability after 24 hrs by MTT assay
|
[PMID: 27496212]
|
MCF7
|
GI50 |
0.94 μM
Compound: Nocodazole
|
Antiproliferative activity against human MCF7 cells after 48 hrs by SRB assay
Antiproliferative activity against human MCF7 cells after 48 hrs by SRB assay
|
[PMID: 27344493]
|
MCF7
|
GI50 |
|
Antiproliferative activity against human MCF7 cells assessed as growth inhibition after 48 hrs by SRB assay
Antiproliferative activity against human MCF7 cells assessed as growth inhibition after 48 hrs by SRB assay
|
[PMID: 25131956]
|
MCF7
|
IC50 |
1.086 μM
Compound: Nocodazole
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 30108815]
|
MCF7
|
IC50 |
1.25 μM
Compound: Nocodazole
|
Antiproliferative activity against human MCF7 cells after 48 hrs by SRB assay
Antiproliferative activity against human MCF7 cells after 48 hrs by SRB assay
|
[PMID: 28988624]
|
MCF7
|
IC50 |
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 30108921]
|
MCF7
|
IC50 |
1.5 μM
Compound: Nocodazole
|
Antiproliferative activity against human MCF7 cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human MCF7 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 28684120]
|
MCF7
|
IC50 |
1.6 μM
Compound: Nocodazole
|
Anticancer activity against human MCF7 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
Anticancer activity against human MCF7 cells assessed as reduction in cell growth incubated for 48 hrs by MTT assay
|
[PMID: 26231080]
|
MCF7
|
IC50 |
1.7 μM
Compound: Nocodazole
|
Cytotoxicity against human MCF7 cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 25599948]
|
MCF7
|
IC50 |
1.76 μM
Compound: Nocodazole
|
Cytotoxicity against human MCF-7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human MCF-7 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 34095841]
|
MDA-MB-231
|
GI50 |
< 0.01 μM
Compound: Nocodazole
|
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by SRB cell proliferation assay
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by SRB cell proliferation assay
|
[PMID: 29089233]
|
MDA-MB-231
|
GI50 |
< 0.01 μM
Compound: Nocodazole
|
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by SRB assay
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by SRB assay
|
[PMID: 27688193]
|
MDA-MB-231
|
IC50 |
< 0.1 μM
Compound: Nocodazole
|
Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 48 hrs by SRB assay
Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 48 hrs by SRB assay
|
10.1039/C0MD00263A
|
MDA-MB-231
|
GI50 |
0.011 μM
Compound: Nacodazole
|
Antiproliferative activity against human MDA-MB-231 cells by SRB assay
Antiproliferative activity against human MDA-MB-231 cells by SRB assay
|
[PMID: 31546197]
|
MDA-MB-231
|
GI50 |
0.017 μM
Compound: Nocadazole
|
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by SRB assay
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by SRB assay
|
[PMID: 25827522]
|
MDA-MB-231
|
GI50 |
0.042 μM
Compound: Nocodazole
|
Anticancer activity against human MDA-MB-231 cells after 48 hrs by SRB assay
Anticancer activity against human MDA-MB-231 cells after 48 hrs by SRB assay
|
[PMID: 27130357]
|
MDA-MB-231
|
GI50 |
0.065 μM
Compound: Nocodazole
|
Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 48 hrs by SRB assay
Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 48 hrs by SRB assay
|
[PMID: 28117204]
|
MDA-MB-231
|
GI50 |
0.15 μM
Compound: Nocodazole
|
Growth inhibition of human MDA-MB-231 cells after 48 hrs by sulforhodamine B assay
Growth inhibition of human MDA-MB-231 cells after 48 hrs by sulforhodamine B assay
|
10.1039/C0MD00177E
|
MDA-MB-231
|
IC50 |
|
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 30108808]
|
MDA-MB-231
|
IC50 |
1.1 μM
Compound: Nocodazole
|
Cytotoxicity against human MDA-MB-231 cells assessed as decrease in cell viability after 24 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells assessed as decrease in cell viability after 24 hrs by MTT assay
|
[PMID: 27496212]
|
MDA-MB-231
|
IC50 |
1.38 μM
Compound: Nacodazole
|
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 31546197]
|
MDA-MB-231
|
IC50 |
1.83 μM
Compound: Nocodazole
|
Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 32717368]
|
MDA-MB-231
|
IC50 |
1.862 μM
Compound: Nocodazole
|
Anticancer activity against human MDA-MB-231 cells after 48 hrs by MTT assay
Anticancer activity against human MDA-MB-231 cells after 48 hrs by MTT assay
|
[PMID: 28789894]
|
MDA-MB-231
|
IC50 |
1.9 μM
Compound: Nocodazole
|
Antiproliferative activity against human MDA-MB-231 cells measured after 48 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells measured after 48 hrs by MTT assay
|
[PMID: 33316752]
|
MDA-MB-453
|
IC50 |
0.91 μM
Compound: Nocodazole
|
Cytotoxicity in human MDA-MB-453 cells incubated for 48 hrs by MTT assay
Cytotoxicity in human MDA-MB-453 cells incubated for 48 hrs by MTT assay
|
[PMID: 28923381]
|
MDR
|
IC50 |
0.07 μM
Compound: nocodazole
|
Antiproliferative activity against LT12 MDR cells by XTT assay after 48 hrs
Antiproliferative activity against LT12 MDR cells by XTT assay after 48 hrs
|
[PMID: 17181164]
|
ME-180
|
IC50 |
1.7 μM
Compound: Nocodazole
|
Anticancer activity against human ME180 cells by MTT assay
Anticancer activity against human ME180 cells by MTT assay
|
10.1039/C4MD00219A
|
MIA PaCa-2
|
IC50 |
|
Antiproliferative activity against human MIAPaCa2 cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human MIAPaCa2 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 30108808]
|
MIA PaCa-2
|
GI50 |
0.95 μM
Compound: Nocodazole
|
Antiproliferative activity against human MIAPaCa2 cells after 48 hrs by SRB assay
Antiproliferative activity against human MIAPaCa2 cells after 48 hrs by SRB assay
|
[PMID: 27344493]
|
MIA PaCa-2
|
GI50 |
|
Antiproliferative activity against human MIAPaCa2 cells assessed as growth inhibition after 48 hrs by SRB assay
Antiproliferative activity against human MIAPaCa2 cells assessed as growth inhibition after 48 hrs by SRB assay
|
[PMID: 25131956]
|
MRC5
|
IC50 |
|
Antiproliferative activity against human MRC5 cells assessed as reduction in cell viability after 48 hrs by MTT assay
Antiproliferative activity against human MRC5 cells assessed as reduction in cell viability after 48 hrs by MTT assay
|
[PMID: 30878833]
|
NCI-H460
|
IC50 |
0.068 μM
Compound: Nocodazole
|
Antiproliferative activity against human NCI-H460 cells after 48 hrs by alamar blue assay
Antiproliferative activity against human NCI-H460 cells after 48 hrs by alamar blue assay
|
[PMID: 21563750]
|
NCI-H460
|
IC50 |
0.15 μM
Compound: Nocodazole
|
Cytotoxicity against human NCI-H460 cells after 48 hrs by XTT assay
Cytotoxicity against human NCI-H460 cells after 48 hrs by XTT assay
|
[PMID: 21705223]
|
NCI-H460
|
IC50 |
0.15 μM
Compound: Nocodazole
|
Antiproliferative activity against human NCI-H460 cells after 48 hrs by XTT assay
Antiproliferative activity against human NCI-H460 cells after 48 hrs by XTT assay
|
[PMID: 20537765]
|
NCI-H460
|
IC50 |
0.15 μM
Compound: nocodazole
|
Cytotoxicity against human NCI-H460 cells after 48 hrs by XTT assay
Cytotoxicity against human NCI-H460 cells after 48 hrs by XTT assay
|
[PMID: 17973361]
|
NCI-H460
|
IC50 |
0.15 μM
Compound: nocodazole
|
Antiproliferative activity against NCI-H460 cells by XTT assay after 48 hrs
Antiproliferative activity against NCI-H460 cells by XTT assay after 48 hrs
|
[PMID: 17181164]
|
NCI-H460
|
IC50 |
0.15 μM
Compound: nocodazole
|
Antiproliferative activity against human NCI-H460 cells by XTT assay
Antiproliferative activity against human NCI-H460 cells by XTT assay
|
[PMID: 19220018]
|
NCI-H460
|
IC50 |
0.15 μM
Compound: Nocodazole
|
Cytotoxic activity against cellular metabolic activity of Lung NCI-H460 tumor cell line using XTT proliferation assay after incubation with the compound for 48 h
Cytotoxic activity against cellular metabolic activity of Lung NCI-H460 tumor cell line using XTT proliferation assay after incubation with the compound for 48 h
|
[PMID: 12852768]
|
NCI-H460
|
IC50 |
0.25 μM
Compound: Nocodazole
|
Antiproliferative activity against human NCI-H460 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
Antiproliferative activity against human NCI-H460 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
|
[PMID: 37252100]
|
NCI-H460
|
IC50 |
2.29 μM
Compound: Nocodazole
|
Cytotoxicity against human NCI-H460 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Cytotoxicity against human NCI-H460 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 34095841]
|
P388
|
IC50 |
> 5 μM
Compound: nocodazole
|
Antiproliferative activity against doxorubicin-resistant mouse P388 cells expressing MDR1 protein after 48 hrs by XTT assay
Antiproliferative activity against doxorubicin-resistant mouse P388 cells expressing MDR1 protein after 48 hrs by XTT assay
|
[PMID: 19220018]
|
P388
|
IC50 |
0.04 μM
Compound: nocodazole
|
Antiproliferative activity against mouse P388 cells after 48 hrs by XTT assay
Antiproliferative activity against mouse P388 cells after 48 hrs by XTT assay
|
[PMID: 19220018]
|
P388
|
IC50 |
0.05 μM
Compound: Nocodazole
|
Antiproliferative activity against ADR-resistant mouse P388 cells after 48 hrs by XTT assay
Antiproliferative activity against ADR-resistant mouse P388 cells after 48 hrs by XTT assay
|
[PMID: 21705223]
|
P388
|
IC50 |
0.05 μM
Compound: nocodazole
|
Antiproliferative activity against mouse adriamycin-resistant P388 cells after 48 hrs by XTT assay
Antiproliferative activity against mouse adriamycin-resistant P388 cells after 48 hrs by XTT assay
|
[PMID: 17973361]
|
P388
|
IC50 |
0.07 μM
Compound: nocodazole
|
Antiproliferative activity against mouse P388 cells after 48 hrs by XTT assay
Antiproliferative activity against mouse P388 cells after 48 hrs by XTT assay
|
[PMID: 17973361]
|
P388
|
IC50 |
0.07 μM
Compound: Nocodazole
|
Antiproliferative activity against mouse P388 cells after 48 hrs by XTT proliferation assay
Antiproliferative activity against mouse P388 cells after 48 hrs by XTT proliferation assay
|
[PMID: 21705223]
|
P388
|
IC50 |
0.08 μM
Compound: Nocodazole
|
Antiproliferative activity against mouse P388 cells after 48 hrs by XTT assay
Antiproliferative activity against mouse P388 cells after 48 hrs by XTT assay
|
[PMID: 20537765]
|
P388
|
IC50 |
0.08 μM
Compound: nocodazole
|
Antiproliferative activity against P388 cells by XTT assay after 48 hrs
Antiproliferative activity against P388 cells by XTT assay after 48 hrs
|
[PMID: 17181164]
|
P388
|
IC50 |
0.17 μM
Compound: Nocodazole
|
Antiproliferative activity against adriamycin-resistant mouse P388 cells after 48 hrs by XTT assay
Antiproliferative activity against adriamycin-resistant mouse P388 cells after 48 hrs by XTT assay
|
[PMID: 20537765]
|
P388
|
IC50 |
0.17 μM
Compound: nocodazole
|
Antiproliferative activity against P388 ADR cells by XTT assay after 48 hrs
Antiproliferative activity against P388 ADR cells by XTT assay after 48 hrs
|
[PMID: 17181164]
|
PANC-1
|
GI50 |
< 0.01 μM
Compound: Nocodazole
|
Antiproliferative activity against human PANC1 cells after 48 hrs by SRB assay
Antiproliferative activity against human PANC1 cells after 48 hrs by SRB assay
|
[PMID: 27688193]
|
PANC-1
|
GI50 |
< 0.01 μM
Compound: Nocadazole
|
Antiproliferative activity against human PANC1 cells after 48 hrs by SRB assay
Antiproliferative activity against human PANC1 cells after 48 hrs by SRB assay
|
[PMID: 25827522]
|
PANC-1
|
GI50 |
0.029 μM
Compound: Nocodazole
|
Anticancer activity against human PANC1 cells after 48 hrs by SRB assay
Anticancer activity against human PANC1 cells after 48 hrs by SRB assay
|
[PMID: 27130357]
|
PC-3
|
IC50 |
1.84 μM
Compound: Nocodazole
|
Cytotoxicity in human PC3 cells incubated for 48 hrs by MTT assay
Cytotoxicity in human PC3 cells incubated for 48 hrs by MTT assay
|
[PMID: 28923381]
|
PC-3
|
IC50 |
2.5 μM
Compound: Nocodazole
|
Cytotoxicity against human PC3 cells assessed as decrease in cell viability after 24 hrs by MTT assay
Cytotoxicity against human PC3 cells assessed as decrease in cell viability after 24 hrs by MTT assay
|
[PMID: 27496212]
|
RKO
|
IC50 |
> 10 μM
Compound: Nocodazole
|
Antiproliferative activity against human RKO cells expressing p27Kip1 after 48 hrs by XTT assay
Antiproliferative activity against human RKO cells expressing p27Kip1 after 48 hrs by XTT assay
|
[PMID: 20537765]
|
RKO
|
IC50 |
> 10 μM
Compound: nocodazole
|
Antiproliferative activity against RKO cells with ectopic-induced p27kip1-expression by XTT assay after 48 hrs
Antiproliferative activity against RKO cells with ectopic-induced p27kip1-expression by XTT assay after 48 hrs
|
[PMID: 17181164]
|
RKO
|
IC50 |
> 10 μM
Compound: nocodazole
|
Antiproliferative activity against human RKO cells containing ecdysone-inducible expression vector of p27kipl by XTT assay
Antiproliferative activity against human RKO cells containing ecdysone-inducible expression vector of p27kipl by XTT assay
|
[PMID: 19220018]
|
RKO
|
IC50 |
> 14 μM
Compound: nocodazole
|
Cytotoxicity against human RKO cells with ectopic-inducible expression of p27kip1 after 48 hrs by XTT assay
Cytotoxicity against human RKO cells with ectopic-inducible expression of p27kip1 after 48 hrs by XTT assay
|
[PMID: 17973361]
|
RKO
|
IC50 |
0.11 μM
Compound: Nocodazole
|
Antiproliferative activity against human RKO cells after 48 hrs by XTT assay
Antiproliferative activity against human RKO cells after 48 hrs by XTT assay
|
[PMID: 20537765]
|
RKO
|
IC50 |
0.11 μM
Compound: nocodazole
|
Cytotoxicity against human RKO cells after 48 hrs by XTT assay
Cytotoxicity against human RKO cells after 48 hrs by XTT assay
|
[PMID: 17973361]
|
RKO
|
IC50 |
0.11 μM
Compound: nocodazole
|
Antiproliferative activity against RKO cells by XTT assay after 48 hrs
Antiproliferative activity against RKO cells by XTT assay after 48 hrs
|
[PMID: 17181164]
|
RKO
|
IC50 |
0.11 μM
Compound: nocodazole
|
Antiproliferative activity against human RKO cells by XTT assay
Antiproliferative activity against human RKO cells by XTT assay
|
[PMID: 19220018]
|
SF-268
|
IC50 |
0.3 μM
Compound: Nocodazole
|
Cytotoxicity against human SF268 cells after 48 hrs by XTT assay
Cytotoxicity against human SF268 cells after 48 hrs by XTT assay
|
[PMID: 21705223]
|
SF-268
|
IC50 |
0.3 μM
Compound: Nocodazole
|
Antiproliferative activity against human SF268 cells after 48 hrs by XTT assay
Antiproliferative activity against human SF268 cells after 48 hrs by XTT assay
|
[PMID: 20537765]
|
SF-268
|
IC50 |
0.3 μM
Compound: nocodazole
|
Cytotoxicity against human SF268 cells after 48 hrs by XTT assay
Cytotoxicity against human SF268 cells after 48 hrs by XTT assay
|
[PMID: 17973361]
|
SF-268
|
IC50 |
0.3 μM
Compound: nocodazole
|
Antiproliferative activity against SF268 cells by XTT assay after 48 hrs
Antiproliferative activity against SF268 cells by XTT assay after 48 hrs
|
[PMID: 17181164]
|
SF-268
|
IC50 |
0.3 μM
Compound: nocodazole
|
Antiproliferative activity against human SF268 cells by XTT assay
Antiproliferative activity against human SF268 cells by XTT assay
|
[PMID: 19220018]
|
SF-268
|
IC50 |
0.3 μM
Compound: Nocodazole
|
Cytotoxic activity against cellular metabolic activity of Glioma SF-268 tumor cell line using XTT proliferation assay after incubation with the compound for 48 h
Cytotoxic activity against cellular metabolic activity of Glioma SF-268 tumor cell line using XTT proliferation assay after incubation with the compound for 48 h
|
[PMID: 12852768]
|
SGC-7901
|
IC50 |
|
Growth inhibition of human SGC7901 cells after 72 hrs by MTT assay
Growth inhibition of human SGC7901 cells after 72 hrs by MTT assay
|
[PMID: 25262051]
|
SGC-7901
|
IC50 |
|
Antiproliferative activity against human SGC7901 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Antiproliferative activity against human SGC7901 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
10.1039/C5MD00150A
|
SK-BR-3
|
IC50 |
0.084 μM
Compound: Nocodazole
|
Growth inhibition of human SKBR3 cells after 48 hrs by MTT assay
Growth inhibition of human SKBR3 cells after 48 hrs by MTT assay
|
[PMID: 22850214]
|
SK-N-SH
|
IC50 |
< 0.1 μM
Compound: Nocodazole
|
Cytotoxicity against human SK-N-SH cells assessed as growth inhibition after 48 hrs by SRB assay
Cytotoxicity against human SK-N-SH cells assessed as growth inhibition after 48 hrs by SRB assay
|
10.1039/C0MD00263A
|
SK-N-SH
|
GI50 |
0.65 μM
Compound: Nocodozole
|
Cytotoxicity against human SK-N-SH cells after 48 hrs by SRB assay
Cytotoxicity against human SK-N-SH cells after 48 hrs by SRB assay
|
[PMID: 20529689]
|
SK-N-SH
|
GI50 |
0.66 μM
Compound: Nocodozole
|
Growth inhibition of human SK-N-SH cells by Sulforhodamine B assay
Growth inhibition of human SK-N-SH cells by Sulforhodamine B assay
|
[PMID: 21106458]
|
SK-OV-3
|
IC50 |
0.08 μM
Compound: Nocodazole
|
Antiproliferative activity against human SKOV3 cells after 48 hrs by alamar blue assay
Antiproliferative activity against human SKOV3 cells after 48 hrs by alamar blue assay
|
[PMID: 21563750]
|
SK-OV-3
|
IC50 |
0.17 μM
Compound: Nocodazole
|
Cytotoxicity against human SKOV3 cells after 48 hrs by XTT assay
Cytotoxicity against human SKOV3 cells after 48 hrs by XTT assay
|
[PMID: 21705223]
|
SK-OV-3
|
IC50 |
0.17 μM
Compound: Nocodazole
|
Antiproliferative activity against human SKOV3 cells after 48 hrs by XTT assay
Antiproliferative activity against human SKOV3 cells after 48 hrs by XTT assay
|
[PMID: 20537765]
|
SK-OV-3
|
IC50 |
0.17 μM
Compound: nocodazole
|
Cytotoxicity against human SKOV3 cells after 48 hrs by XTT assay
Cytotoxicity against human SKOV3 cells after 48 hrs by XTT assay
|
[PMID: 17973361]
|
SK-OV-3
|
IC50 |
0.17 μM
Compound: nocodazole
|
Antiproliferative activity against SKOV3 cells by XTT assay after 48 hrs
Antiproliferative activity against SKOV3 cells by XTT assay after 48 hrs
|
[PMID: 17181164]
|
SK-OV-3
|
IC50 |
0.17 μM
Compound: nocodazole
|
Antiproliferative activity against human SKOV3 cells by XTT assay
Antiproliferative activity against human SKOV3 cells by XTT assay
|
[PMID: 19220018]
|
SK-OV-3
|
IC50 |
0.17 μM
Compound: Nocodazole
|
Cytotoxic activity against cellular metabolic activity of Ovary SKOV3 tumor cell line using XTT proliferation assay after incubation with the compound for 48 h
Cytotoxic activity against cellular metabolic activity of Ovary SKOV3 tumor cell line using XTT proliferation assay after incubation with the compound for 48 h
|
[PMID: 12852768]
|
SW480
|
IC50 |
0.12 μM
Compound: Nocodazole
|
Antiproliferative activity against human SW480 cells after 48 hrs by alamar blue assay
Antiproliferative activity against human SW480 cells after 48 hrs by alamar blue assay
|
[PMID: 21563750]
|
U2OS
|
EC50 |
50 nM
Compound: Nocodazole
|
Induction of mitotic arrest in human U2OS cells assessed as mitotic index after 72 hrs by microscopic analysis
Induction of mitotic arrest in human U2OS cells assessed as mitotic index after 72 hrs by microscopic analysis
|
[PMID: 24900887]
|
Z-138
|
IC50 |
0.31 μM
Compound: Nocodazole
|
Antiproliferative activity against human Z138 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
Antiproliferative activity against human Z138 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay
|
[PMID: 37252100]
|